<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32325953</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Study of Gene Expression Changes in Human Spinal and Oculomotor Neurons; Identifying Potential Links to Sporadic ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">448</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes11040448</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that causes compromised function of motor neurons and neuronal death. However, oculomotor neurons are largely spared from disease symptoms. The underlying causes for sporadic ALS as well as for the resistance of oculomotor neurons to disease symptoms remain poorly understood. In this bioinformatic-analysis, we compared the gene expression profiles of spinal and oculomotor tissue samples from control individuals and sporadic ALS patients. We show that the genes <i>GAD2</i> and <i>GABRE</i> (involved in GABA signaling), and <i>CALB1</i> (involved in intracellular Ca<sup>2+</sup> ion buffering) are downregulated in the spinal tissues of ALS patients, but their endogenous levels are higher in oculomotor tissues relative to the spinal tissues. Our results suggest that the downregulation of these genes and processes in spinal tissues are related to sporadic ALS disease progression and their upregulation in oculomotor neurons confer upon them resistance to ALS symptoms. These results build upon prevailing models of excitotoxicity that are relevant to sporadic ALS disease progression and point out unique opportunities for better understanding the progression of neurodegenerative properties associated with sporadic ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Aayan N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Davidson Academy, Reno, NV 89503, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2096-6334</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Nevada, Reno, NV 89557, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 GM103650</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009802" MajorTopicYN="N">Oculomotor Nerve</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">CALB1</Keyword><Keyword MajorTopicYN="N">GABA signaling</Keyword><Keyword MajorTopicYN="N">GABRE</Keyword><Keyword MajorTopicYN="N">GAD2</Keyword><Keyword MajorTopicYN="N">GEO2R</Keyword><Keyword MajorTopicYN="N">excitotoxicity</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32325953</ArticleId><ArticleId IdType="pmc">PMC7230244</ArticleId><ArticleId IdType="doi">10.3390/genes11040448</ArticleId><ArticleId IdType="pii">genes11040448</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P.F., Pagani W., Lodin D., Orozco G., Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., Sendtner M., Brunetti M., Ossola I., Calvo A., et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain. 2012;135:784&#x2013;793. doi: 10.1093/brain/awr366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr366</ArticleId><ArticleId IdType="pmc">PMC3286333</ArticleId><ArticleId IdType="pubmed">22366794</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 1995;10:61&#x2013;66. doi: 10.1038/ng0595-61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0595-61</ArticleId><ArticleId IdType="pubmed">7647793</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A.E., Weishaupt J.H., Andersen P.M., Ludolph A.C., Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genet. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Foran E., Trotti D. Glutamate Transporters and the Excitotoxic Path to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis. Antioxid. Redox Sign. 2009;11:1587&#x2013;1602. doi: 10.1089/ars.2009.2444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2444</ArticleId><ArticleId IdType="pmc">PMC2842587</ArticleId><ArticleId IdType="pubmed">19413484</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Martin L.J., Kuncl R.W. Decreased Glutamate Transport by the Brain and Spinal-Cord in Amyotrophic-Lateral-Sclerosis. N. Engl. J. Med. 1992;326:1464&#x2013;1468. doi: 10.1056/NEJM199205283262204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199205283262204</ArticleId><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotti D., Aoki M., Pasinelli P., Berger U.V., Danbolt N.C., Brown R.H., Hediger M.A. Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J. Biol. Chem. 2001;276:576&#x2013;582. doi: 10.1074/jbc.M003779200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M003779200</ArticleId><ArticleId IdType="pubmed">11031254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Yamashita T., Aizawa H., Tsuji S., Kakita A., Takahashi H., Kwak S. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol. Dis. 2012;45:1121&#x2013;1128. doi: 10.1016/j.nbd.2011.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.033</ArticleId><ArticleId IdType="pubmed">22226999</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: A reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 2002;193:73&#x2013;78. doi: 10.1016/S0022-510X(01)00661-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00661-X</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyt K.R., Arden S.R., Aizenman E., Reynolds I.J. Reverse Na+/Ca2+ exchange contributes to glutamate-induced intracellular Ca2+ concentration increases in cultured rat forebrain neurons. Mol. Pharmacol. 1998;53:742&#x2013;749. doi: 10.1124/mol.53.4.742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.53.4.742</ArticleId><ArticleId IdType="pubmed">9547366</ArticleId></ArticleIdList></Reference><Reference><Citation>Brittain M.K., Brustovetsky T., Sheets P.L., Brittain J.M., Khanna R., Cummins T.R., Brustovetsky N. Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+/Ca2+ exchanger. Neurobiol. Dis. 2012;46:109&#x2013;117. doi: 10.1016/j.nbd.2011.12.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.051</ArticleId><ArticleId IdType="pmc">PMC3299854</ArticleId><ArticleId IdType="pubmed">22249110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A., Spiller K.J., Towne C., Kanning K.C., Choe G.T., Geber A., Akay T., Aebischer P., Henderson C.E. Neuronal Matrix Metalloproteinase-9 is a Determinant of Selective Neurodegeneration. Neuron. 2014;81:333&#x2013;348. doi: 10.1016/j.neuron.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885. doi: 10.1007/s00401-017-1708-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1708-8</ArticleId><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzardo M., Taiana M., Rizzo F., Aguila Benitez J., Nijssen J., Allodi I., Melzi V., Bresolin N., Comi G.P., Hedlund E., et al. Synaptotagmin 13 is neuroprotective across motor neuron diseases. Acta Neuropathol. 2020 doi: 10.1007/s00401-020-02133-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02133-x</ArticleId><ArticleId IdType="pmc">PMC7181443</ArticleId><ArticleId IdType="pubmed">32065260</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I., Comley L., Nichterwitz S., Nizzardo M., Simone C., Benitez J.A., Cao M., Corti S., Hedlund E. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci. Rep. 2016;6:25960. doi: 10.1038/srep25960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25960</ArticleId><ArticleId IdType="pmc">PMC4867585</ArticleId><ArticleId IdType="pubmed">27180807</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.T., Chen J.H., Guan T.Y., Yao H., Zhang W.P., Guan Z.L., Wang Y.Q. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson&#x2019;s disease. BMC Syst. Biol. 2019;13:10. doi: 10.1186/s12918-019-0680-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12918-019-0680-4</ArticleId><ArticleId IdType="pmc">PMC6341689</ArticleId><ArticleId IdType="pubmed">30665415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H.X., Zhang Y.S. Identification and bioinformatics analysis of overlapping differentially expressed genes in depression, papillary thyroid cancer and uterine fibroids. Exp. Ther. Med. 2018;15:4810&#x2013;4816. doi: 10.3892/etm.2018.6023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6023</ArticleId><ArticleId IdType="pmc">PMC5952074</ArticleId><ArticleId IdType="pubmed">29805500</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R., Domrachev M., Lash A.E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207&#x2013;210. doi: 10.1093/nar/30.1.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.1.207</ArticleId><ArticleId IdType="pmc">PMC99122</ArticleId><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangond F., Hwang D., Camelo S., Pasinelli P., Frosch M.P., Stephanopoulos G., Stephanopoulos G., Brown R.H., Gullans S.R. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genom. 2004;16:229&#x2013;239. doi: 10.1152/physiolgenomics.00087.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00087.2001</ArticleId><ArticleId IdType="pubmed">14645737</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockington A., Ning K., Heath P.R., Wood E., Kirby J., Fusi N., Lawrence N., Wharton S.B., Ince P.G., Shaw P.J. Unravelling the enigma of selective vulnerability in neurodegeneration: Motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 2013;125:95&#x2013;109. doi: 10.1007/s00401-012-1058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1058-5</ArticleId><ArticleId IdType="pmc">PMC3535376</ArticleId><ArticleId IdType="pubmed">23143228</ArticleId></ArticleIdList></Reference><Reference><Citation>Yudkoff M., Daikhin Y., Horyn O., Nissim I., Nissim I. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia. 2008;49:73&#x2013;75. doi: 10.1111/j.1528-1167.2008.01841.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2008.01841.x</ArticleId><ArticleId IdType="pmc">PMC2722878</ArticleId><ArticleId IdType="pubmed">19049594</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Holodkov N., Klima R., Grilli F., Guarnaccia C., Nizzardo M., Rizzo F., Garcia R., Feiguin F. Downregulation of glutamic acid decarboxylase in Drosophila TDP-43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses. Sci. Rep. 2018;8:1809. doi: 10.1038/s41598-018-19802-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19802-3</ArticleId><ArticleId IdType="pmc">PMC5789004</ArticleId><ArticleId IdType="pubmed">29379112</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigel E., Steinmann M.E. Structure, Function, and Modulation of GABA(A) Receptors. J. Biol. Chem. 2012;287:40224&#x2013;40231. doi: 10.1074/jbc.R112.386664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R112.386664</ArticleId><ArticleId IdType="pmc">PMC3504738</ArticleId><ArticleId IdType="pubmed">23038269</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelands T.R., Fisher J.L., Bianchi M., Macdonald R.L. Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor channels formed by epsilon subunit-containing isoforms. Mol. Pharmacol. 1999;55:168&#x2013;178. doi: 10.1124/mol.55.1.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.55.1.168</ArticleId><ArticleId IdType="pubmed">9882711</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen M., Wafford K.A., Wingrove P., Ebert B. Pharmacology of GABA(A) receptors exhibiting different levels of spontaneous activity. Eur. J. Pharmacol. 2003;476:17&#x2013;24. doi: 10.1016/S0014-2999(03)02125-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-2999(03)02125-3</ArticleId><ArticleId IdType="pubmed">12969744</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H. Three functional facets of calbindin D-28k. Front. Mol. Neurosci. 2012;5:25. doi: 10.3389/fnmol.2012.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2012.00025</ArticleId><ArticleId IdType="pmc">PMC3304297</ArticleId><ArticleId IdType="pubmed">22435048</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47:165&#x2013;174. doi: 10.1016/j.ceca.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Patai R., Nogradi B., Engelhardt J.I., Siklos L. Calcium in the pathomechanism of amyotrophic lateral sclerosis&#x2014;Taking center stage? Biochem. Biophys. Res. Commun. 2017;483:1031&#x2013;1039. doi: 10.1016/j.bbrc.2016.08.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.08.089</ArticleId><ArticleId IdType="pubmed">27545602</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu M.E., Ho B.K., Mohamed A.H., Labella V., Smith R.G., Appel S.H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic-lateral-sclerosis. Ann. Neurol. 1994;36:846&#x2013;858. doi: 10.1002/ana.410360608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360608</ArticleId><ArticleId IdType="pubmed">7998770</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Torrelo J., Rodriguez-Rosell D., Nunez-Abades P., Carrascal L., Torres B. Glutamate modulates the firing rate in oculomotor nucleus motoneurons as a function of the recruitment threshold current. J. Physiol. Lond. 2012;590:3113&#x2013;3127. doi: 10.1113/jphysiol.2011.226985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2011.226985</ArticleId><ArticleId IdType="pmc">PMC3406394</ArticleId><ArticleId IdType="pubmed">22570384</ArticleId></ArticleIdList></Reference><Reference><Citation>Carunchio I., Mollinari C., Pieri M., Merlo D., Zona C. GABA(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2008;28:1275&#x2013;1285. doi: 10.1111/j.1460-9568.2008.06436.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2008.06436.x</ArticleId><ArticleId IdType="pubmed">18973555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>